You are here

Astellas

Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo

BioSpace

Fri, 09/22/23 - 11:53 am

urothelial cancer

clinical trials

Taysha ends work on gene therapy after Astellas walks away, FDA requests randomized trial

Fierce Biotech

Wed, 09/20/23 - 08:47 am

Taysha Gene Therapies

Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of Izervay for Geographic Atrophy

PR Newswire

Tue, 09/19/23 - 10:28 am

clinical trials

geographic atrophy

EU clears review of Xtandi in earlier-stage prostate cancer

Pharmaphorum

Wed, 09/13/23 - 06:02 pm

prostate cancer

Astellas withdraws lawsuit challenging Medicare drug price negotiation plans

Reuters

Thu, 09/7/23 - 10:44 am

prostate cancer

Inflation Reduction Act

The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023

BioSpace

Wed, 08/23/23 - 11:11 am

Eiger Pharmaceuticals

The 10 drugs that CMS might wrangle into negotiations

Beckers Hospital Review

Wed, 08/16/23 - 10:16 am

Bristol Myers Squibb

Boehringer Ingelheim

Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood

PR Newswire

Wed, 08/9/23 - 10:36 pm

Iveric drug approved for type of vision loss as rival’s safety draws scrutiny

BioPharma Dive

Sun, 08/6/23 - 09:25 pm

geographic atrophy

Go or no go? Biogen and Astellas head towards key PDUFAs

EP Vantage

Sat, 07/29/23 - 10:45 pm

SAGE Therapeutics

major depressive disorder

postpartum depression

geographic atrophy

Astellas notches another protein degrader pact with $21M upfront for PeptiDream

Fierce Biotech

Tue, 07/25/23 - 10:08 am

protein degradation

Astellas' Zolbetuximab Is a Promising Therapy for HER2-Negative Gastric Cancer

Xtalks

Mon, 07/17/23 - 06:54 pm

Astellas buys rights to 4D Molecular’s technology in latest gene therapy deal

BioPharma Dive

Mon, 07/10/23 - 09:34 pm

4D Molecular Therapeutics

Astellas to withhold prostate cancer drug from contract pharmacies

Beckers Hospital Review

Thu, 07/6/23 - 10:03 pm

prostate cancer

Biopharma buyouts bounce back

EP Vantage

Wed, 07/5/23 - 10:17 am

Horizon Therapeutics

Astellas reports data from Phase IIIb trial to treat VMS due to menopause

Clinical Trials Arena

Wed, 06/28/23 - 09:58 am

clinical trials

Mimetas and Astellas expand partnership to include automation and application support

Biopharma Reporter

Tue, 06/27/23 - 10:27 pm

organ-on-a-chip

Astellas delves deeper into protein degrading drugs with Cullgen deal

BioPharma Dive

Thu, 06/15/23 - 09:55 am

protein degradation

With Iveric Bio buyout, Astellas CEO Okamura acted on the company's mantra to be 'aggressive'

Fierce Pharma

Tue, 06/13/23 - 10:43 am

Pages